In our study, we established a potential ceRNA regulatory network involving three NRDEGs (TLR4, ELAVL1, AHR), providing new insights into AIS diagnosis and more effective targeted therapies against these NRDEGs. Here, TLR4 is linked to androgen insensitivity syndrome.